{"log_id": 6700507193872280442, "direction": 0, "words_result_num": 47, "words_result": [{"probability": {"variance": 0.025765, "average": 0.908227, "min": 0.399729}, "location": {"width": 1076, "top": 280, "height": 38, "left": 196}, "words": "用时,应严密观察可能发生的毒性反应。(5)孕药(雌激素类),长时间与磺"}, {"probability": {"variance": 0.013375, "average": 0.965278, "min": 0.39402}, "location": {"width": 1080, "top": 322, "height": 38, "left": 191}, "words": "药合用可导致避孕的可靠性减少,并增加经期外出血的机会。(6溶栓药物与"}, {"probability": {"variance": 0, "average": 0.999705, "min": 0.99927}, "location": {"width": 146, "top": 308, "height": 61, "left": 1354}, "words": "药品监督"}, {"probability": {"variance": 0.005799, "average": 0.961462, "min": 0.662675}, "location": {"width": 1062, "top": 363, "height": 38, "left": 191}, "words": "磺胺药合用时,可能增大其潜在的性作用。(7)肝毒性药物与磺胺药合用时"}, {"probability": {"variance": 0.020201, "average": 0.923239, "min": 0.496265}, "location": {"width": 1082, "top": 402, "height": 38, "left": 191}, "words": "可能引起肝毒性反应率的增高。对此类患者尤其是用药时间较长及以往有肝病史"}, {"probability": {"variance": 0, "average": 0.999844, "min": 0.999673}, "location": {"width": 137, "top": 399, "height": 59, "left": 1366}, "words": "备案专"}, {"probability": {"variance": 0.021492, "average": 0.921802, "min": 0.518352}, "location": {"width": 1080, "top": 445, "height": 36, "left": 191}, "words": "应监测开功能:(.8)光敏药物与胺药合用可能发生光敏的相加作用(9)接"}, {"probability": {"variance": 0.017986, "average": 0.930867, "min": 0.482051}, "location": {"width": 1076, "top": 484, "height": 36, "left": 191}, "words": "毫磺胺药治疗老对维生素K的需要量培力。(10)乌将托品在酸性尿中可分解产"}, {"probability": {"variance": 0.013659, "average": 0.949616, "min": 0.422815}, "location": {"width": 1076, "top": 525, "height": 36, "left": 194}, "words": "生醛,后者可与磺形成不溶沉淀物:使发生结晶尿的危险增加,因此不宜"}, {"probability": {"variance": 0.024044, "average": 0.918638, "min": 0.47618}, "location": {"width": 1080, "top": 564, "height": 38, "left": 191}, "words": "两药合月。(11)磺药可取代保泰松的血浆蛋白结合部位,当两者合用时可增"}, {"probability": {"variance": 0.011365, "average": 0.928328, "min": 0.503227}, "location": {"width": 1078, "top": 605, "height": 36, "left": 191}, "words": "强保泰松的作用。(12)磺吡酮( sulfinpyrazone)与磺类药物司用时可减少"}, {"probability": {"variance": 0.014709, "average": 0.94524, "min": 0.573135}, "location": {"width": 1080, "top": 646, "height": 38, "left": 191}, "words": "后者自肾小管的分泌,其血药浓度升高且持久:从面产生毒性,因此在应用磺"}, {"probability": {"variance": 0.019853, "average": 0.933184, "min": 0.442396}, "location": {"width": 1082, "top": 685, "height": 38, "left": 189}, "words": "期间或在应用其治疗后可能需要调楚磺胺药的剂量当磺吡酮疗程较长时,对"}, {"probability": {"variance": 0.004726, "average": 0.966194, "min": 0.646819}, "location": {"width": 1080, "top": 728, "height": 36, "left": 191}, "words": "胺药的血药浓度宜进行监测,有助干刑量的词整,保证安全用药。(13)与洋"}, {"probability": {"variance": 0.009354, "average": 0.9602, "min": 0.496993}, "location": {"width": 1082, "top": 765, "height": 41, "left": 191}, "words": "地黄类或叶酸合用时,后者的吸收减少,血药浓度降低,因此须随对观察洋地黄"}, {"probability": {"variance": 0.027112, "average": 0.901533, "min": 0.363181}, "location": {"width": 1076, "top": 811, "height": 36, "left": 194}, "words": "类的作用与疗效。(14)与丙磺舒合用,会降低肾小管磺胺抖泌量,致肢药"}, {"probability": {"variance": 0.013314, "average": 0.945377, "min": 0.505211}, "location": {"width": 1046, "top": 849, "height": 36, "left": 191}, "words": "浓度上升,作用延长,容易中毒。(15)与新霉素合用,新素抑制肠道"}, {"probability": {"variance": 0.022125, "average": 0.94372, "min": 0.433198}, "location": {"width": 434, "top": 893, "height": 34, "left": 191}, "words": "影响本品在内分解,作用低"}, {"probability": {"variance": 0.008478, "average": 0.95713, "min": 0.537607}, "location": {"width": 1073, "top": 929, "height": 38, "left": 198}, "words": "【药物过量】当每天用量达到或超过4g求血清药物浓度超过50gmi,不良反"}, {"probability": {"variance": 0.015573, "average": 0.938185, "min": 0.517564}, "location": {"width": 1078, "top": 970, "height": 38, "left": 191}, "words": "应或毒性反应增多。过量时多出现恶心和呕吐症状,对干过量的处理,首先应洗"}, {"probability": {"variance": 0.014304, "average": 0.947865, "min": 0.367837}, "location": {"width": 1066, "top": 1012, "height": 38, "left": 191}, "words": "胄,继而静脉补液利尿,静脉给予碳酸氢钠碱化处理,繁惕现少尿和无尿症状"}, {"probability": {"variance": 0.021409, "average": 0.922544, "min": 0.367818}, "location": {"width": 1080, "top": 1055, "height": 34, "left": 189}, "words": "若发生无,应时进行透析治疗。若出现高铁血红蛋口症(出现紫绀)时,应"}, {"probability": {"variance": 0.024034, "average": 0.902534, "min": 0.388414}, "location": {"width": 1082, "top": 1094, "height": 38, "left": 189}, "words": "静脉缓给予亚中兰(美兰)每公斤体重1~g考其他合适沪疗。若有严重"}, {"probability": {"variance": 0.006752, "average": 0.968134, "min": 0.704787}, "location": {"width": 616, "top": 1135, "height": 38, "left": 194}, "words": "的硫血红蛋白血症时,则可进行输血替换治疗"}, {"probability": {"variance": 0.011617, "average": 0.959571, "min": 0.445296}, "location": {"width": 1073, "top": 1176, "height": 38, "left": 198}, "words": "药理毒理】药理作用:动物试验与体外实验发现初氮磺吡啶(SSZ)能与结缔"}, {"probability": {"variance": 0.020352, "average": 0.916908, "min": 0.454465}, "location": {"width": 1082, "top": 1213, "height": 41, "left": 187}, "words": "组织、肛组织、肠黏膜结合,具有抗炎和免流调节作用,临床上分别用柳氮磺北"}, {"probability": {"variance": 0.017012, "average": 0.938835, "min": 0.524621}, "location": {"width": 1082, "top": 1258, "height": 38, "left": 189}, "words": "及其主要代谢物5一氨基水杨酸和心脑啶对溃疡性结肠炎病人以直肠给药方"}, {"probability": {"variance": 0.02839, "average": 0.910158, "min": 0.420801}, "location": {"width": 1078, "top": 1297, "height": 38, "left": 189}, "words": "式进行泠疗,结舆显示起主要炸用的是5氨水杨酸,它能抑制溃疡性结版炎"}, {"probability": {"variance": 0.011294, "average": 0.946645, "min": 0.62446}, "location": {"width": 1076, "top": 1341, "height": 38, "left": 191}, "words": "的急性发作并延长其缓解期。柳氮演吡淀及其要代谢物对风湿性关节炎的治疗"}, {"probability": {"variance": 0.003244, "average": 0.974423, "min": 0.713447}, "location": {"width": 1069, "top": 1384, "height": 34, "left": 191}, "words": "作用仍在研究中。澎性研究:生殖毒性:雄性大鼠给药800(4800mg/m2)"}, {"probability": {"variance": 0.018181, "average": 0.948062, "min": 0.393442}, "location": {"width": 1028, "top": 1420, "height": 38, "left": 196}, "words": "g/kg/day,出现与人类一样的精子减少及不育的反应,停药后可自行恢复"}, {"probability": {"variance": 0.017042, "average": 0.943336, "min": 0.363216}, "location": {"width": 1178, "top": 1450, "height": 54, "left": 189}, "words": "于人用量的大鼠及子试验,结果表明对雌性生殖力和胎儿无损害。对孕的药业"}, {"probability": {"variance": 0.015819, "average": 0.949731, "min": 0.44743}, "location": {"width": 1076, "top": 1500, "height": 38, "left": 191}, "words": "影响仍充足够研究资料。士丁动物试验不能完全等同于人类反应,孕妇用药需译"}, {"probability": {"variance": 0.027759, "average": 0.883694, "min": 0.443642}, "location": {"width": 1082, "top": 1542, "height": 41, "left": 189}, "words": "域。遗传毒性:在AcE试验及151781小鼠淋巴瘤细胞 HGPKI基因试验中柳氨磺"}, {"probability": {"variance": 0.021339, "average": 0.932314, "min": 0.40364}, "location": {"width": 1082, "top": 1580, "height": 41, "left": 191}, "words": "吡啶(S)均无致突变作用,但在大鼠,小鼠骨髓微核试验及小鼠外周B试"}, {"probability": {"variance": 0.008857, "average": 0.94834, "min": 0.546168}, "location": {"width": 1080, "top": 1624, "height": 41, "left": 191}, "words": "验、姐妹染色体交换试验、染色体琦变试验及人类淋巴细胞微核试验中其致突变"}, {"probability": {"variance": 0.017793, "average": 0.92101, "min": 0.452673}, "location": {"width": 1082, "top": 1663, "height": 41, "left": 191}, "words": "作用尚不明确。致癌性:用F344/N大鼠和LB6C3i1小鼠做为期两年的研究,大鼠"}, {"probability": {"variance": 0.006498, "average": 0.957871, "min": 0.696587}, "location": {"width": 598, "top": 1711, "height": 34, "left": 189}, "words": "给药量分别是84(496mg/m2)mg/kg/d"}, {"probability": {"variance": 0.018556, "average": 0.821233, "min": 0.591568}, "location": {"width": 324, "top": 1708, "height": 34, "left": 877}, "words": " 168(991mg/m2)rg/ki/de"}, {"probability": {"variance": 0.014695, "average": 0.909395, "min": 0.503695}, "location": {"width": 1139, "top": 1724, "height": 70, "left": 185}, "words": "37.51910g/a2)mg/sg/day,雄性大鼠尿道膀比通透细胞乳头瘤发生率显著升"}, {"probability": {"variance": 0.021116, "average": 0.925698, "min": 0.407131}, "location": {"width": 1046, "top": 1788, "height": 38, "left": 194}, "words": "岛,性大鼠给药组37.5mg/kg/day有2例(4%)肾脏出现通透细胞乳头瘤"}, {"probability": {"variance": 0.009074, "average": 0.95112, "min": 0.618601}, "location": {"width": 1082, "top": 1823, "height": 45, "left": 191}, "words": "尿道膀痤、肾癌出现率的增加与肾结石,通透上皮细胞增生相关。小鼠给药量"}, {"probability": {"variance": 0.021118, "average": 0.912006, "min": 0.393866}, "location": {"width": 1082, "top": 1868, "height": 41, "left": 191}, "words": "分别为6752025mgm2)mg/kg/dy,1350mg/ kg/ day.2700mg/kg/day,雌,小"}, {"probability": {"variance": 0.012883, "average": 0.941812, "min": 0.669535}, "location": {"width": 621, "top": 1909, "height": 38, "left": 191}, "words": "鼠肝细胞痛、癌的发生率较对照组有显著提高"}, {"probability": {"variance": 0.012556, "average": 0.958396, "min": 0.396682}, "location": {"width": 1071, "top": 1948, "height": 43, "left": 198}, "words": "【药代动力学】口服柳氮比啶的绝对生物利用度小于15%,本品口服后在胃和"}, {"probability": {"variance": 0.014868, "average": 0.943676, "min": 0.368324}, "location": {"width": 1080, "top": 1989, "height": 41, "left": 194}, "words": "小肠上不崩解,至回肠末段和结肠才崩解释出相氮磺吡啶,被该部位细菌分解"}, {"probability": {"variance": 0.022484, "average": 0.909635, "min": 0.350516}, "location": {"width": 1078, "top": 2033, "height": 43, "left": 194}, "words": "为5一氨基水杨酸和磺吡啶,胺吡啶人部分在肠道被吸,而5-氨基水杨"}], "language": -1}